Sunday, July 31, 2011

International Stem Cell Corporation Chairman Ken Aldrich Interviewed by Ellis Martin

"The Ellis Martin Report features interviews with exciting, potentially undervalued small and mid-cap publicly traded companies, showcased to an audience of potential retail investors during market hours throughout the United States."

Ellis Martin with Ken Aldrich of International Stem Cell Corporation (ISCO.OB)
Listen to full interview here: or you can read a Transcript of the conversation here:
(Scroll down to view this week's Radio Schedule for ISCO.)

“International Stem Cell Corporation trades under the symbol ISCO.OB on the Over the Counter Bulletin Board and is based in Carlsbad, California where Ellis Martin had the pleasure of interviewing Executive Chairman Kenneth Aldrich.

International Stem Cell has developed a process to derive stem cells similar to Embryonic Stem Cells without the need for fertilized embryos and with minimal exposure to non-human cells. These factors provide ISCO a unique leadership role in the field of regenerative cell therapy. Additionally, Lifeline Cell Technology, a wholly-owned subsidiary of International Stem Cell Corporation (ISCO) develops, manufactures and markets high-quality human primary cells, stem cells, media and reagents for sale to pharmaceutical, academic and government scientists.

The company's management pioneered the development of the normal human cell culture market through the creation of Clonetics® Corporation in the 1980s and has over 20 years combined experience in research, development, manufacturing, quality control, marketing and sales of human cell culture products. Lifeline Cell Tech’s products are distributed in the United States and Europe.”

Monday, August 1st at 1:00pm

WVNJ-NY/NJ - AM1160      

Tuesday, August 2nd at 10:00am
KCEO - AM1000    
San Diego/Orange County/LA Beach Cities

Tuesday, August 2nd at 9:30am and Friday, August 5th at 3:30pm
WSBR-AM - 740 FM 95.5  
Boca Raton, West Palm Beach, Ft. Lauderdale, Miami

Mondays and Wednesdays at 1:00pm
WBNM-AM 1120
Boston and New England through: WESO AM 970 and WCRN AM 830

Ellis Martin Report

International Stem Cell Corporation

International Stem Cell Corporation is a paid sponsor of The Ellis Martin Report

Click here to listen to the entire interview:

No comments:

Post a Comment